हिंदी

Background of Project Launching


The three most commonly occurring cancers in India are those of the breast, uterine cervix and lip/oral cavity. Together they account for approximately 34% of all cancers and constitute a public health priority in India. Significant financial catastrophe is experienced by the cancer patient and his/her family on diagnosis and treatment, resulting in psychological stress and financial burden.

The three most commonly occurring cancers in India are those of the breast, uterine cervix and oral cavity. Together they account for approximately 34% of all cancers and constitute a public health priority in India. Significant financial catastrophe is experienced by the cancer patient and his/her family on diagnosis and treatment, resulting in psychological stress and financial burden.

To make cancer care accessible to people living in districts and bring down the incidence of its preventable forms, Tata Memorial Centre (TMC) conceptualized a project titled “Access to Affordable Cancer Care for One and All” in 2015 with the larger goal that patients from the rest of Maharashtra state do not have to come down to Mumbai with families in town, putting their lives and livelihoods on hold for cancer treatment.

This project is being supported by Mylan Laboratories Ltd. (A Viatris Company) as part of its corporate social responsibility.

Mylan Laboratories Ltd. has approached TMC to join as a project partner in an endeavour to create models of rural and semi-urban cancer healthcare delivery through training and capacity building of cancer-care personnel and standardization of treatment and reduction in cost to patients.

This project was launched in June 2016 on a pilot basis in six districts of Maharashtra namely Amravati, Jalgaon, Nagpur, Gadchiroli, Pune and Nashik with the theme “Good Health for All”.

Project Expansion: In 2021, this project was expanded to 10 other districts of Maharashtra namely Jalna, Palghar, Satara, Ratnagiri, Sindhudurga, Chandrapur, Wardha, Raigad, Akola, Ahmednagar.

National Scale-Up: In 2019 the project has been scaled up at the national level in 6 states namely Punjab, West Bengal, Andhra Pradesh, Nagaland, Odisha and Bihar. We have selected one district from each state on a pilot basis. It will be rolled out full-fledged once the pilot study completes.

MoU: TMC had an MoU with the Public Health Department of Maharashtra.

Show More


Vision & Mission


The vision of this project is to provide cancer care at the doorstep of poor and needy people by establishing cancer care facilities at every district level.To achieve this vision the project has established certain goals by providing technical support to the state health departments in the effective implementation of cancer and tobacco control programs.

Followings are the goals of project:

  • To provide training and capacity building for the early detection, screening and prevention of common cancers for strengthening the existing government manpower’s skill in Preventive Oncology, Surgical Oncology and Medical Oncology

  • To provide technical support to the state health department for the set-up of Preventive Oncology and Cancer Day Care Centre Services at the district level

  • To create awareness about cancer and the harmful effects of tobacco on health in the community

Doctor's Manual

Project Principal Investigator

Dr. Pankaj Chaturvedi

Deputy Director - Dr. Pankaj Chaturvedi


Dr. Pankaj Chaturvedi is Head Neck Cancer Surgeon and Deputy Director of Center for Cancer Epidemiology at Tata Memorial Centre, Mumbai. He has been invited as visiting faculty in 44 institutions in 32 countries. He is the editor of the Textbook of Head and Neck Surgery and the Associate Editor of the International Journal of Head and Neck surgery. He has authored more than 200 papers in international peer reviewed journals. He is the Principal Investigator of several pivotal randomized clinical trials. His main area of interest is prevention and early detection of oral cancer. He is the recipient of the prestigious NIH R01 grant for research on tobacco carcinogenesis.


Show More